• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Chronic Kidney Disease Phenotype of HFpEF: Unique Cardiac Characteristics.

作者信息

Kirkman Danielle L, Carbone Salvatore, Canada Justin M, Trankle Cory, Kadariya Dinesh, Buckley Leo, Billingsley Hailey, Kidd Jason M, Van Tassell Benjamin W, Abbate Antonio

机构信息

Virginia Commonwealth University, Richmond, Virginia.

Virginia Commonwealth University, Richmond, Virginia.

出版信息

Am J Cardiol. 2021 Mar 1;142:143-145. doi: 10.1016/j.amjcard.2020.12.012. Epub 2020 Dec 24.

DOI:10.1016/j.amjcard.2020.12.012
PMID:33333073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8425110/
Abstract
摘要

相似文献

1
The Chronic Kidney Disease Phenotype of HFpEF: Unique Cardiac Characteristics.射血分数保留的心力衰竭的慢性肾病表型：独特的心脏特征
Am J Cardiol. 2021 Mar 1;142:143-145. doi: 10.1016/j.amjcard.2020.12.012. Epub 2020 Dec 24.
2
Tissue Doppler annular velocities, NT-proBNP and exercise capacity in healthy elderly.健康老年人的组织多普勒环周速度、N末端B型利钠肽原与运动能力
Age Ageing. 2008 May;37(3):336-9. doi: 10.1093/ageing/afm170. Epub 2007 Nov 20.
3
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.射血分数保留的心力衰竭中性别差异的病理生理学：详细的有创血流动力学和超声心动图分析。
JACC Heart Fail. 2019 Mar;7(3):239-249. doi: 10.1016/j.jchf.2019.01.004.
4
Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.静脉注射铁剂可降低合并慢性心力衰竭和肾功能不全的贫血患者的N末端脑钠肽前体水平。
J Am Coll Cardiol. 2007 Oct 23;50(17):1657-65. doi: 10.1016/j.jacc.2007.07.029.
5
Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction.肾功能、N 末端 pro-B 型利钠肽、前内皮素原肽和射血分数保留心力衰竭患者。
Peptides. 2019 Jan;111:112-117. doi: 10.1016/j.peptides.2018.04.003. Epub 2018 Apr 21.
6
Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.If 通道抑制对射血分数保留的心力衰竭患者血流动力学状态和运动耐量的影响：一项随机试验。
J Am Coll Cardiol. 2013 Oct 8;62(15):1330-8. doi: 10.1016/j.jacc.2013.06.043. Epub 2013 Jul 31.
7
Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction.心肺运动试验在射血分数降低和射血分数保留的心力衰竭患者中反映出相似的病理生理学和疾病严重程度。
Eur J Prev Cardiol. 2014 Jul;21(7):847-54. doi: 10.1177/2047487313476962. Epub 2013 Feb 4.
8
Comparisons of prognostic factors between young and elderly patients with chronic heart failure.慢性心力衰竭青年和老年患者预后因素的比较。
Geriatr Gerontol Int. 2015 Apr;15(4):435-42. doi: 10.1111/ggi.12293. Epub 2014 Apr 15.
9
Comparison of the Diastolic Stress Test With a Combined Resting Echocardiography and Biomarker Approach to Patients With Exertional Dyspnea: Diagnostic and Prognostic Implications.比较舒张期压力测试与静息超声心动图和生物标志物联合应用于运动性呼吸困难患者：诊断和预后意义。
JACC Cardiovasc Imaging. 2019 May;12(5):771-780. doi: 10.1016/j.jcmg.2017.10.008. Epub 2018 Feb 14.
10
Tissue Doppler imaging adds incremental value in predicting exercise capacity in patients with congestive heart failure.组织多普勒成像在预测充血性心力衰竭患者的运动能力方面具有额外价值。
Heart Vessels. 2007 Jul;22(4):237-44. doi: 10.1007/s00380-006-0961-x. Epub 2007 Jul 20.

引用本文的文献

1
Salt sensitivity and myocardial fibrosis: unraveling the silent cardiovascular remodeling.盐敏感性与心肌纤维化：揭示隐匿的心血管重塑
Front Pharmacol. 2025 Jun 13;16:1626492. doi: 10.3389/fphar.2025.1626492. eCollection 2025.
2
Glucagon-like Peptide-1 Receptor Agonists in the Context of Pathophysiology of Diverse Heart Failure with Preserved Ejection Fraction Phenotypes: Potential Benefits and Mechanisms of Action.射血分数保留的不同类型心力衰竭病理生理学背景下的胰高血糖素样肽-1受体激动剂：潜在益处及作用机制
Card Fail Rev. 2024 Oct 16;10:e14. doi: 10.15420/cfr.2024.06. eCollection 2024.
3
Hyperlactataemia is a marker of reduced exercise capacity in heart failure with preserved ejection fraction.高乳酸血症是射血分数保留型心力衰竭运动能力降低的一个标志物。
ESC Heart Fail. 2024 Oct;11(5):2557-2565. doi: 10.1002/ehf2.14794. Epub 2024 May 2.
4
Early Renal Denervation Attenuates Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction.早期肾脏去神经支配可减轻射血分数保留的心力衰竭患者的心脏功能障碍。
J Am Heart Assoc. 2024 Feb 20;13(4):e032646. doi: 10.1161/JAHA.123.032646. Epub 2024 Feb 14.
5
Modeling the physiological roles of the heart and kidney in heart failure with preserved ejection fraction during baroreflex activation therapy.在压力反射激活治疗期间，对射血分数保留心力衰竭中心脏和肾脏的生理作用进行建模。
Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H597-H607. doi: 10.1152/ajpheart.00329.2022. Epub 2022 Aug 19.
6
Mimicking Metabolic Disturbance in Establishing Animal Models of Heart Failure With Preserved Ejection Fraction.在建立射血分数保留的心力衰竭动物模型中模拟代谢紊乱
Front Physiol. 2022 May 3;13:879214. doi: 10.3389/fphys.2022.879214. eCollection 2022.

本文引用的文献

1
Acute Kidney Injury Induces Remote Cardiac Damage and Dysfunction Through the Galectin-3 Pathway.急性肾损伤通过半乳糖凝集素-3途径诱导远隔心肌损伤和功能障碍。
JACC Basic Transl Sci. 2019 Oct 28;4(6):717-732. doi: 10.1016/j.jacbts.2019.06.005. eCollection 2019 Oct.
2
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2018年年报：美国肾脏疾病流行病学
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21.
3
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.白细胞介素-1 阻断剂治疗射血分数保留的心力衰竭患者。
Circ Heart Fail. 2018 Aug;11(8):e005036. doi: 10.1161/CIRCHEARTFAILURE.118.005036.
4
Galectin-3 inhibition prevents adipose tissue remodelling in obesity.半乳糖凝集素-3抑制可预防肥胖症中的脂肪组织重塑。
Int J Obes (Lond). 2016 Jun;40(6):1034-8. doi: 10.1038/ijo.2016.19. Epub 2016 Feb 8.
5
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.肾功能作为广泛心力衰竭患者预后的预测指标。
Circulation. 2006 Feb 7;113(5):671-8. doi: 10.1161/CIRCULATIONAHA.105.580506.